1Montagnier L. 25 Years after HIV Discovery: Prospects for Cure and Vaccine ( Nobel Lecture ) [ J ]. Angewandte Chemie International Edition, 2009, 48 (32): 5815 -5826. 被引量：1
2Koff W C. HIV vaccine development: challenges and op- portunities towards solving the HIV vaccine - neutralizing antibody problem [ J ]. Vaccine, 2012, 30 (29) : 4310 - 4315. 被引量：1
3Chhatbar C, Mishra R, Kumar A, et al. HIV vaccine: hopes and hurdles [ J]. Drug discovery today, 2011, 16 (21) : 948-956. 被引量：1
4Ross A L, Brgtve A, Scarlatti G, et al. Progress towardsdevelopment of an, HIV vaccine: report of the AIDS Vac- cine 2009 Conference[ J]. The Lancet infectious diseases, 2010, 10(5) : 305-316. 被引量：1
5Girard M P, Osmanov S, Assossou O M, et al. Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review[ J]. Vaccine, 2011, 29 (37) : 6191 -6218. 被引量：1
6Klein F, Mouquet H, Dosenovic P, et al. Antibodies in HIV - 1 vaccine development and therapy [ J ]. Science, 2013, 341 (6151 ) : 1199 - 1204. 被引量：1
7Gupta S, Termini J M, Raffa F N, et al. Vaccination with a fusion protein that introduces HIV - 1 Gag antigen into a multi- trimer CD4 + 0L construct results in enhanced CD8 + T cell responses and protection from viral challenge by vaccinia - Gag [ J ]. Journal of Virology, 2013 : JVI. 02229 - 13. 被引量：1
8Jardine J, Julien J P, Menis S, et al. Rational HIV im- munogen design to target specific germline B cell receptors [J]. Science, 2013, 340(6133): 711 -716. 被引量：1
9Hansen S G, Piatak Jr M, Ventura A B, et al. Immune clearance of highly pathogenic SIV infection [ J ]. Nature, 2013, 502(7469) : 100 - 104. 被引量：1
10Center R J, Miller A, Wheatley A K, et al. Utility of the Sindbis replicon system as an Env - targeted HIV vaccine [J]. Vaccine, 2013. 被引量：1
